Упрощенная HTML-версия
28
157.
Stamler J. Diabetes, other risk factors, and 12- yr cardiovascular mortality for men
screened in the Multiple Risk Factor Intervention Trial / J. Stamler, О. Vaccaro, J.
Neaton D // Diabetes Care. - 1993. - Vol.16. - P. 434-444.
158.
Stapleton A. Binding of uropathogenic Escherichia coli R45 to glycolipids
extracted from vaginal epithelial cells is dependent on histo- blood group secretor
status / A. Stapleton, Е. Nudelman, Н. Clausen // J. Clin. Invest. - 1992. - № 90. - Р.
965-972.
159.
Tooke J. Vascular disiase in diabetes. A report of hemovasculae study group / J.
Tooke. - France. : Servier. - 2001. - Р. 63.
160.
Tschoepe D. Platelets in diabetes: the role in haemostatic regulation in
atherosclerosis / D. Tschoepe, Р. Rosen, В. Schwippert // Semin. Thromb. Hemost. -
1993. - Vol.19. - P. 122-128.
161.
Vinik Aaron I. Platelet dysfunction in type 2 diabetes / I. Vinik Aaron, E. Tomris,
N. Roger // Diabetes. - 2001. - Vol.24, № 8. - Р. 1476-1485.
162.
Wetterhall G.F. Trends in Diabetes and Diabetic Complicacion / G.F. Wetterhall,
D.R. Olson, F. Destefano // Diabetes Care. - 1992. - Vol.15. - P. 960-967.
163.
Wiman B. Plasminogen activator inhibitor in plasma: its role in thrombotic
disease / В. Wiman // Thromb. Haemost. - 1995. - Vol.74. - P. 71-76.
164.
Wolf S.P. Free radical biology and medicine / S.P. Wolf, R.T. Dean // Biochem J.
- 1991. - Vol.10. - P. 140-150.
165.
Yokoyama H. Transient extreme insulin resistence in shock during diabetic
ketoasidosis / H. Yokoyama, Т. Wasada, Y. Shimizu // Endocrinol. Japan. - 1992. -
Vol.39, № 6. - Р. 571-576.
166.
Zhanel G.G. Asymptomatic bacteriuria. Which patients should be treated? / G.G.
Zhanel, G.К. Harding, D.R. Guay // Arch. Intern. Med. - 1990. - № 150. - Р. 1389-
1396.